15. BEERS CRITERIA:
1.NITROFURANTOIN不建議用在65歲以上的長輩~
因其肺臟、肝臟與神經副作用,尤其是長期使用更明
顯
2.肌酸酐清除率<30 ML/MINUTE ,不要使用
NITROFURANTOIN,因為體內濃度會升高很多
Nitrofurantoin is identified in the Beers Criteria as a potentially
inappropriate medication to be avoided in patients 65 years and older
(independent of diagnosis or condition) due to its potential for pulmonary
toxicity, hepatotoxicity and peripheral neuropathy, particularly when given
long-term; safer alternatives exist. Avoid use in patients with a CrCl less
than 30 mL/minute or for long-term suppressive therapy (Beers Criteria
[AGS 2019]).
16. PHARMACY QUALITY ALLIANCE
(PQA):
65歲以上的長輩,若連續使用NITROFURANTOIN
90天以上,算是高風險情形~產生毒性
Nitrofurantoin (when cumulative day supply is greater than 90 days) is
identified as a high-risk medication in patients 65 years and older on
the PQA's Use of High-Risk Medications in the Elderly (HRM)
performance measure, a safety measure used by the Centers for
Medicare and Medicaid Services (CMS) for Medicare plans (PQA 2017).